Hence, the significant changes in expression observed in the d20:1 species that did not reach statistical significance in the d18:1 species suggest future therapeutics targeting GGs, as the d20:1 form may prove to be a more effective therapeutic target than the d18:1 species [ 74 ].
← all excerpts
Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.
1
—
—